About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Drug Development Research
›
Top Articles
Drug Development Research
Pharmacology
5.1
(top 3%)
Impact Factor
5.4
(top 3%)
extended IF
73
(top 5%)
H-Index
1.6K
authors
3.4K
papers
46.2K
citations
4.5K
citing journals
24.6K
citing authors
Most Cited Articles of Drug Development Research
Title
Year
Citations
Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen
1995
1.2K
Magnetic nanoparticles for drug delivery
2006
645
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics
2020
513
Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors
2006
364
Comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted glycine peptide and peptoid oligomers
1995
335
Ectonucleotidases: Some recent developments and a note on nomenclature
2001
331
Anticonvulsant activity of (+)-5-methyl-10, 11-dihydro-5H-dibenzo[a, d]cyclohepten-5, 10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
1982
290
Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs
1992
256
Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo [a, d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
1982
234
Next-Generation Antimalarial Drugs: Hybrid Molecules as a New Strategy in Drug Design
2010
208
Integrin alpha(v)beta(3)-Targeted Cancer Therapy
2008
205
The Role of miR-21 in Cancer
2015
202
Targeted nanoparticles for detecting and treating cancer
2006
185
1,4-Dihydropyridine Ca2+ channel antagonists and activators: A comparison of binding characteristics with pharmacology
1984
181
Thymosthenic effects of ritanserin (R 55667), a centrally acting serotonin-S2 receptor blocker
1986
179
Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects
1988
167
Molecular Architecture of G Protein-Coupled Receptors
1996
164
Biochemical, neurophysiological, and behavioral effects of Wy-45,233 and other identified metabolites of the antidepressant venlafaxine
1991
162
Time-dependent sensitization as the cornerstone for a new approach to pharmacotherapy: Drugs as foreign/stressful stimuli
1988
159
Gangliosides in treatment of neural injury and disease
1988
156
Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies
2004
152
Current drug targets for Alzheimer's disease treatment
2002
146
Viruses and their uses in nanotechnology
2006
140
Extracellular purine metabolism
1996
138
Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine
1994
134
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.